Appareil pulmonaire
IMMUNO ADDICT (GFPC 06-2018)
A multicenter phase II, open-label, non-randomized study evaluating Platinum-Pemetrexed-Atezolizumab (+/- Bevacizumab) for patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutations or ALK rearrangement progressing after Targeted therapies
Paris
CATHERINE DANIEL